Panacea Biotec: Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 ('SEBI LODR Regulations') - Update On Ongoing Tax Litigation Reported Earlier Under Integrated Filing (Governance)

We are pleased to inform you that the Companys wholly owned subsidiary Panacea Biotec Pharma Ltd. (PBPL) has received an Order dated 10.03.2026 issued by the Deputy Commissioner of State Tax Maharashtra in the appeal filed by PBPL in May 2025 against the demand order of Rs.1.58 Crore issued by Adjudicating Officer in FY 2024-25. In the above said order the total tax demand has been reduced from Rs.1.58 Crore to Rs.0.81 Crore.A detailed disclosure in this regard is annexed herewith.